The Global Respiratory Disease Testing Market size is expected to grow from USD 5.59 billion in 2023 to USD 6.72 billion by 2028, at a CAGR of 3.77% during.
The NGS-Based RNA-Sequencing Market size is expected to grow from USD 3.09 billion in 2023 to USD 7.72 billion by 2028, at a CAGR of 20.06% during the.